Neuilly sur Seine, France

Annie Kamoun

This inventor holds 1 USPTO granted patent. Top assignee: Adir Et Compagnie. Active years: 1992.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Annie Kamoun

Introduction

Annie Kamoun is a notable inventor based in Neuilly sur Seine, France. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of memory disorders. Her work is characterized by a commitment to advancing medical science and improving the quality of life for individuals affected by cognitive decline.

Latest Patents

Annie Kamoun holds a patent for a pharmaceutical composition that includes 1,3,7-trimethyl-8-[3-(4-diethylaminocarbonyl-piperazino) propyl] xanthine and its physiologically tolerable acid addition salts. This invention is aimed at the preparation of medicaments for treating memory disorders, intellectual disorders of aging, and Alzheimer's disease. This patent reflects her dedication to addressing critical health issues through innovative solutions.

Career Highlights

Throughout her career, Annie has demonstrated a strong focus on research and development in the pharmaceutical industry. Her work at Adir Et Compagnie has allowed her to collaborate with other experts in the field, further enhancing her contributions to medical science.

Collaborations

Annie Kamoun has worked alongside her coworker, Gilbert Regnier, to advance their research initiatives. Their collaboration has been instrumental in the development of new therapeutic approaches in the pharmaceutical sector.

Conclusion

Annie Kamoun's innovative work in pharmaceuticals showcases her commitment to improving treatments for memory-related disorders. Her patent and collaborations highlight her significant role in advancing medical research and developing effective solutions for cognitive health.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…